BETACILLIN DROPS- amoxicillin and clavulanate potassium suspension

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Buy It Now

Active ingredient:

AMOXICILLIN ANHYDROUS (UNII: 9EM05410Q9) (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9), CLAVULANATE POTASSIUM (UNII: Q42OMW3AT8) (CLAVULANIC ACID - UNII:23521W1S24)

Available from:

MWI Animal Health

Administration route:

ORAL

Prescription type:

PRESCRIPTION

Therapeutic indications:

Betacillin Drops are indicated in the treatment of: Dogs: Skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing Staphylococcus aureus , non-β-lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., and E. coli . Periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria. Betacillin Drops has been shown to be clinically effective for treating cases of canine periodontal disease. Cats: Skin and soft tissue infections such as wounds, abscesses, and cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing Staphylococcus aureus, non-β-lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., E. coli, Pasteurella multocida, and Pasteurella spp. Urinary tract infections (cystitis) due to susceptible strains of E. coli . Therapy may be initiated with Betac

Product summary:

Betacillin Drops are supplied in 15-mL bottles containing 50 mg of amoxicillin/12.5 mg of clavulanic acid per mL. Approved by FDA under ANADA # 200-709 Augmentin® is a trademark owned by GlaxoSmithKline. Manufactured for: Cronus Pharma LLC, East Brunswick, NJ 08816. Contact No: 1-844-227-6687 (1-844-2-CRONUS) Made in India Iss.09/21 Distributed by: MWI Boise, ID 83705 www.VetOne.net

Authorization status:

Abbreviated New Animal Drug Application

Summary of Product characteristics

                                BETACILLIN DROPS- AMOXICILLIN AND CLAVULANATE POTASSIUM SUSPENSION
MWI ANIMAL HEALTH
----------
BETACILLIN™ DROPS
(Amoxicillin and Clavulanate Potassium for Oral Suspension)
_FOR VETERINARY ORAL SUSPENSION_
_FOR USE IN DOGS AND CATS_
CAUTION
Federal law restricts this drug to use by or on the order of a
licensed veterinarian.
DESCRIPTION
Betacillin Drops is an orally administered formulation comprised of
the broad-spectrum
antibiotic amoxicillin trihydrate and the β-lactamase inhibitor,
clavulanate potassium (the
potassium salt of clavulanic acid).
Amoxicillin trihydrate is a semisynthetic antibiotic with a broad
spectrum of bactericidal
activity against many gram-positive and gram-negative, aerobic and
anaerobic
microorganisms. It does not resist destruction by β-lactamases;
therefore, it is not
effective against β-lactamase-producing bacteria. Chemically, it is
D(-)-α-amino-p-
hydroxybenzyl penicillin trihydrate.
Clavulanic acid, an inhibitor of β-lactamase enzymes, is produced by
the fermentation of
_Streptomyces clavuligerus_. Clavulanic acid by itself has only weak
antibacterial activity.
Chemically, clavulanate potassium is potassium
z-(3R,5R)-2-β-hydroxyethylidene clavam-
3-carboxylate.
CLINICAL PHARMACOLOGY
Betacillin Drops is stable in the presence of gastric acid and is not
significantly influenced
by gastric or intestinal contents. The 2 components are rapidly
absorbed resulting in
amoxicillin and clavulanic acid concentrations in serum, urine, and
tissues similar to
those produced when each is administered alone.
Amoxicillin and clavulanic acid diffuse readily into most body tissues
and fluids with the
exception of brain and spinal fluid, which amoxicillin penetrates
adequately when
meninges are inflamed. Most of the amoxicillin is excreted unchanged
in the urine.
Clavulanic acid’s penetration into spinal fluid is unknown at this
time. Approximately 15%
of the administered dose of clavulanic acid is excreted in the urine
within the first 6
hours.
Betacillin Drops combines the distinctive pro
                                
                                Read the complete document